Heron Therapeutics, Inc. (HRTX) vs Kalaris Therapeutics Inc (KLRS)
A side-by-side comparison of Heron Therapeutics, Inc. and Kalaris Therapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HRTX
Heron Therapeutics, Inc.
$0.34HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
KLRS
Kalaris Therapeutics Inc
$2.90HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — HRTX vs KLRS
growth of $100 · dividends reinvested · last 10yHRTX -97.6% (-31.2%/yr)KLRS -99.1% (-37.3%/yr)HRTX compounded faster over this window
HRTX KLRS
HRTX vs KLRS: by the numbers
- •HRTX is the larger company ($64M vs $63M market cap).
- •Both run net losses; KLRS's is the smaller (0.00% vs -22.52% net margin).
Metrics side by side
Valuation
| Metric | HRTX | KLRS |
|---|---|---|
| P/S ratio | 0.42 | N/A |
| P/B ratio | 10.95 | 1.10 |
Profitability
| Metric | HRTX | KLRS |
|---|---|---|
| Gross margin | 70.07% | 0.00% |
| Operating margin | -7.19% | 0.00% |
| Net margin | -22.52% | 0.00% |
| ROE | -492.89% | -76.75% |
| ROIC | -6.79% | -52.40% |
Growth (annualized)
| Metric | HRTX | KLRS |
|---|---|---|
| Revenue CAGR (5Y) | 12.73% | N/A |
| Total return CAGR (5Y) | -48.61% | -81.13% |
Frequently asked
- How have HRTX and KLRS total returns compared?
- Over the past 5 years, HRTX delivered -48.61% and KLRS delivered -81.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.